Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AISA-021(cilnidipine), a...

Genprex, Inc. a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its research collaborators were selected to...

Forge Biologics, a member of Ajinomoto Bio-Pharma Services and leading manufacturer of genetic medicines, today announced it will be the adeno-associated virus (AAV) development and manufacturing...

A. Menarini Diagnostics, a company bringing advanced solutions to the in vitro diagnostic market, and Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier,...

IKA, a global company in laboratory and analytical equipment, and process technology, extends its range of accessories and sensors for the award-winning HABITAT research bioreactor. This 3-in-1...

Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra™—the latest addition to its LSA® and LSAXT label-free high-throughput...

Corundum Systems Biology, a leading investment company  dedicated to advancing life-changing systems biology solutions for human health and well-being, today announced it has appointed Jessica...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Calliditas Therapeutics for the exclusive...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the company’s Life Science business achieved EXCiPACT cGMP (current Good Manufacturing...

Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Johnson & Johnson for LAZCLUZE™ (lazertinib). LAZCLUZE™.

Albertsons Companies, Inc. pharmacies are now offering the latest monovalent mRNA COVID vaccines from Pfizer and Moderna along with the annual flu vaccine, in anticipation of a challenging flu and...

Cygnus Technologies both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have leveraged...